β-Adrenoceptor-induced inhibition of rat splenocyte prolifeation: Cytokine gene transcription as the target of action

Immunobiology

Volumn 206, Issue 4, 2002, Pages 345-353

  Xie, Yufen ^a   Frede, Stilla ^a   Harnish, Michael J ^a   Exton, Michael S ^a   Schedlowski, Manfred ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CATECHOLAMINE; CYTOKINE; INTERLEUKIN 2; ISOPRENALINE; MESSENGER RNA; METHOXAMINE; MITOGENIC AGENT; PROPRANOLOL; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CONCANAVALIN A; QUINOXALINE DERIVATIVE;

ADRENERGIC SYSTEM; ANIMAL BEHAVIOR; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONDITIONING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENERVATION; EXPERIMENTAL MODEL; GENETIC TRANSCRIPTION; IMMUNE DEFICIENCY; IN VITRO STUDY; INHIBITION KINETICS; MALE; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SPLEEN CELL; SPLEEN SURGERY; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; GENETICS; IMMUNOLOGY; INNERVATION; LYMPHOCYTE ACTIVATION; METABOLISM; SPLEEN;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ANIMALS; CONCANAVALIN A; INTERLEUKIN-2; ISOPROTERENOL; LYMPHOCYTE ACTIVATION; MALE; METHOXAMINE; QUINOXALINES; RATS; RECEPTORS, ADRENERGIC, BETA; RNA, MESSENGER; SPLEEN; TRANSCRIPTION, GENETIC;

EID: 0036776225     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00185     Document Type: Article

References (30)

1. ADER, R., D. L. FELTEN, and N. COHEN (eds). 2001. Psychoneuroimmunology. Academic Press, San Diego, CA, 500 pp.
2. KOHM, A. P., and V. M. SANDERS. 2000. Norepinephrine: a messenger from the brain to the immune system. Immunology Today 21: 539.
3. ELENKOV, I. J., R. L. WILDER, G. P. CHROUSOS, and E. S. VIZI. 2001. The sympathetic nerve - An integrative interface between two supersystems: The brain and the immune system. Pharmacological Reviews 52: 595.
4. ADER, R., and N. COHEN. 2001. Psychoneuroimmunology: Conditioning and Immunity. In: Ader, R., Felten, D. L., Cohen, N. (eds). 2001. Psychoneuroimmunology. Academic Press, San Diego, CA, 3.
5. EXTON, M. S., S. VON HORSTEN, M. SCHULT, J. VOGE., T. STRUBEL, S. DONATH, C. STEIN-MULLER, H. SEELIGER, E. NAGEL, J. WESTERMANN, and M. SCHEDLOWSKI. 1998. Behaviorally conditioned immunosuppression using cyclosporin A: central nervous system reduces IL-2 production via splenic innervation. J. Neuroimmunol. 88: 182.
6. EXTON, M. S., M. SCHULT, S. DONATH, T. STRUBEL, U. BODE, A. DEL REY, J. WESTERMANN, and M. SCHEDLOWSKI. 1999. Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 276: R1710.
7. EXTON, M. S., A. K. VON AUER, A. BUSKE-KIRSCHBAUM, U. STOCKHORST, U. GOBEL, and M. SCHEDLOWSKI. 2000. Pavlovian conditioning of immune function: animal investigation and the challenge of human application. Behav. Brain Res. 110: 129.
8. EXTON, M. S., J. HERKLOTZ, J. WESTERMANN, and M. SCHEDLOWSKI. 2001. Behavioral conditioning in the rat: an in-vivo model to investigate the molecular mechanisms and clinical implications of brain-immune communication. Immunological Reviews (in press).
9. VON HORSTEN, S., M. S. EXTON, M. SCHULT, E. NAGEL, M. STALP, G. SCHWEITZER, J. VOGE, A. del REY, M. SCHEDLOWSKI, and J. WESTERMANN. 1998. Behaviorally conditioned effects of cyclosporin A on the immune system of rats: specific alterations of blood leukocyte numbers and decrease of granulocyte function. J. Neuroimmunol. 85: 193.
10. WEIHE, E., D. NOHR, S. MICHEL, S. MULLER, H. J. ZENTEL, T. FIND, and J. KREKEL. 1991. Molecular anatomy of the neuro-immune connection. Int. J. Neurosci. 59: 1.
11. STEVENS-FELTEN, S. Y., and D. L. BELLINGER. 1997. Noradrenergic and peptidergic innervation of lymphoid organs. Chem. Immunol. 69: 99.
12. SANDERS, V. M., D. J. KASPROWICZ, A. P. KOHM, and M. A. SWANSON. 2001. Neurotransmitter receptors on lymphocytes and other lymphoid cells. In: Ader, R., Felten, D. L., Cohen, N. (eds) (2001) Psychoneuroimmunology. PP. 161-196, Academic Press, San Diego.
13. CHOMCZYNSKI, P., and N. SACCHI. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-chloroform extraction. Analytical Biochem. 162: 156.
14. BENSCHOP, R. J., M. RODRIGUEZ-FEUERHAHN, and M. SCHEDLOWSKI. 1996. Catecholamine-induced leukocytosis: Early observations, current research, and future directions. Brain Behav. Immun. 10: 77.
15. MAISEL, A. S., P. FOWLER, A. REARDEN, H. J. MOTULSKY, and M. C. MICHEL. 1989. New method for isolation of human lymphocyte subsets reveals differential regulation of beta-Adrenergic receptors by terbutaline treatment. Clin. Pharmacol. Ther. 46: 29.
16. RAMER-QUINN, D. S., R. A. BAKER, and V. M. SANDERS. 1997. Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J. Immunol. 159: 4857.
17. RAMER-QUINN, D. S., M. A. SWANSON, W. T. LEE, and V M. SANDERS. 2000. Cytokine production by naive and primary effector CD4+ T cells exposed to norepinephrine. Brain Behav. Immun. 14: 239.
18. SANDERS, V. M., R. A. BAKER, D. S. RAMER-QUINN, D. J. KASPROWICZ, B. A. FUCHS, and N. E. STREET. 1997. Differential expression of the beta-2-adrenergic receptor by Th1 and Th2 clones: Implications for cytokine production and B cell help. J. Immunol. 158: 4200.
19. KAMMER, G. M. 1988. The adenylate cyclase-cAMP-protein kinase: A pathway and regulation of the immune response. Immunol. Today 9: 222.
20. CARLSON, S. L., and K. TRAUTH, 1994. Enhancement Of Beta-Adrenergic-Induced aAMP accumulation in activated T-cells. J. Cell Physiol. 161: 39.
21. CARLSON, S. L., W. H. BROOKS, and T. L. ROSZMAN. 1989. Neurotransmitter-lymphocyte interactions: Dual receptor modulation of lymphocyte proliferation and cAMP production. J. Neuroimmunol. 24: 155.
22. MADDEN, K. S. 2001. Catecholamines, sympathetic nerves, and immunity. In: Ader, R., Felten, D. L., Cohen, N. (eds) (2001) Psychoneuroimmunology. PP. 197-216, Academic Press, San Diego.
23. BARTIK, M. M., W. H. BROOKS, and T. L. ROSZMAN. 1993. Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: Lack of correlation between inhibition of T cell proliferation and cAMP accumulation. Cell Immunol. 148: 408.
24. BARTIK, M. M., G. P. BAUMAN, W. H. BROOKS, and T. L. ROSZMAN. 1994. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells. Cell Immunol. 158: 116.
25. CHEN, D., and E. V. ROTHENBERG. 1994. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med. 179: 931.
26. TAMIR, A., and N. ISAKOV. 1994. Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes. Evidence that cAMP alters PKC-induced transcription regulation of members of the jun and fos family of genes. J. Immunol. 152: 3391.
27. 1-adrenergic receptorson leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J. Neuroimmunol. 71: 223.
28. +) cells. J. Neuroimmun. 74: 159.
29. FELSNER, P., D. HOFER, I. RINNER, H. MANGGE, M. GRUBER, W. KORSATKO, and K. SCHAUENSTEIN. 1992. Continuous in vivo treatment with catecholamines suppresses in vitro reactivity of rat peripheral blood T-lymphocytes via α-mediated mechanisms. J. Neuroimmunol. 57: 47.
30. SCHAUENSTEIN, K., P. FELSNER, I. RINNER, P. M. LIEBMANN, J. R. STEVENSON, J. WESTERMANN, H. S. HAAS, R. L. COHEN, and D. A. CHAMBERS. 2000. In vivo immunomodulation by peripheral adrenergic and cholinergic agonists/antagonists in rat and mouse models. Ann. N. Y. Acad. Sci. 917: 618.